nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—Discomfort—Prednisolone—psoriatic arthritis	0.00291	0.00291	CcSEcCtD
Pentoxifylline—Angioedema—Triamcinolone—psoriatic arthritis	0.00291	0.00291	CcSEcCtD
Pentoxifylline—Haemoglobin—Prednisone—psoriatic arthritis	0.00291	0.00291	CcSEcCtD
Pentoxifylline—Angioedema—Methylprednisolone—psoriatic arthritis	0.00291	0.00291	CcSEcCtD
Pentoxifylline—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.0029	0.0029	CcSEcCtD
Pentoxifylline—Haemorrhage—Prednisone—psoriatic arthritis	0.00289	0.00289	CcSEcCtD
Pentoxifylline—Erythema—Betamethasone—psoriatic arthritis	0.00289	0.00289	CcSEcCtD
Pentoxifylline—Erythema—Dexamethasone—psoriatic arthritis	0.00289	0.00289	CcSEcCtD
Pentoxifylline—Malaise—Triamcinolone—psoriatic arthritis	0.00287	0.00287	CcSEcCtD
Pentoxifylline—Pancytopenia—Methotrexate—psoriatic arthritis	0.00287	0.00287	CcSEcCtD
Pentoxifylline—Malaise—Methylprednisolone—psoriatic arthritis	0.00287	0.00287	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Pentoxifylline—Oedema—Prednisolone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Pentoxifylline—Shock—Prednisolone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Pentoxifylline—Convulsion—Triamcinolone—psoriatic arthritis	0.00276	0.00276	CcSEcCtD
Pentoxifylline—Tachycardia—Prednisolone—psoriatic arthritis	0.00276	0.00276	CcSEcCtD
Pentoxifylline—Convulsion—Methylprednisolone—psoriatic arthritis	0.00275	0.00275	CcSEcCtD
Pentoxifylline—Hypertension—Triamcinolone—psoriatic arthritis	0.00275	0.00275	CcSEcCtD
Pentoxifylline—Hypertension—Methylprednisolone—psoriatic arthritis	0.00274	0.00274	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Pentoxifylline—Myalgia—Triamcinolone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Pentoxifylline—Myalgia—Methylprednisolone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Pentoxifylline—Anxiety—Methylprednisolone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Pentoxifylline—Infestation NOS—Methotrexate—psoriatic arthritis	0.00269	0.00269	CcSEcCtD
Pentoxifylline—Infestation—Methotrexate—psoriatic arthritis	0.00269	0.00269	CcSEcCtD
Pentoxifylline—Drowsiness—Methotrexate—psoriatic arthritis	0.00269	0.00269	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00269	0.00269	CcSEcCtD
Pentoxifylline—Flushing—Prednisone—psoriatic arthritis	0.00268	0.00268	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00268	0.00268	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00268	0.00268	CcSEcCtD
Pentoxifylline—Discomfort—Triamcinolone—psoriatic arthritis	0.00268	0.00268	CcSEcCtD
Pentoxifylline—Discomfort—Methylprednisolone—psoriatic arthritis	0.00267	0.00267	CcSEcCtD
Pentoxifylline—Dry mouth—Triamcinolone—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Pentoxifylline—Angioedema—Betamethasone—psoriatic arthritis	0.00264	0.00264	CcSEcCtD
Pentoxifylline—Angioedema—Dexamethasone—psoriatic arthritis	0.00264	0.00264	CcSEcCtD
Pentoxifylline—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00262	0.00262	CcSEcCtD
Pentoxifylline—Confusional state—Methylprednisolone—psoriatic arthritis	0.00262	0.00262	CcSEcCtD
Pentoxifylline—Immune system disorder—Prednisone—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Pentoxifylline—Malaise—Betamethasone—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Pentoxifylline—Malaise—Dexamethasone—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Pentoxifylline—Oedema—Triamcinolone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Pentoxifylline—Arrhythmia—Prednisone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Pentoxifylline—Infection—Triamcinolone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Pentoxifylline—Sweating—Methotrexate—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Pentoxifylline—Infection—Methylprednisolone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Pentoxifylline—Shock—Triamcinolone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Pentoxifylline—Insomnia—Prednisolone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Pentoxifylline—Shock—Methylprednisolone—psoriatic arthritis	0.00255	0.00255	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00255	0.00255	CcSEcCtD
Pentoxifylline—Epistaxis—Methotrexate—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Pentoxifylline—Tachycardia—Triamcinolone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Pentoxifylline—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Pentoxifylline—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Pentoxifylline—Erythema—Prednisone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00251	0.00251	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00251	0.00251	CcSEcCtD
Pentoxifylline—Convulsion—Betamethasone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Pentoxifylline—Convulsion—Dexamethasone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Pentoxifylline—Hypertension—Dexamethasone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Pentoxifylline—Hypertension—Betamethasone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Pentoxifylline—Myalgia—Betamethasone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Pentoxifylline—Myalgia—Dexamethasone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Pentoxifylline—Anxiety—Dexamethasone—psoriatic arthritis	0.00245	0.00245	CcSEcCtD
Pentoxifylline—Anxiety—Betamethasone—psoriatic arthritis	0.00245	0.00245	CcSEcCtD
Pentoxifylline—Discomfort—Dexamethasone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Pentoxifylline—Discomfort—Betamethasone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Pentoxifylline—Haemoglobin—Methotrexate—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Pentoxifylline—Hypotension—Methylprednisolone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Pentoxifylline—Haemorrhage—Methotrexate—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Pentoxifylline—Hepatitis—Methotrexate—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Pentoxifylline—Vision blurred—Prednisone—psoriatic arthritis	0.00237	0.00237	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00237	0.00237	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Pentoxifylline—Oedema—Dexamethasone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Pentoxifylline—Oedema—Betamethasone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Pentoxifylline—Insomnia—Triamcinolone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Pentoxifylline—Insomnia—Methylprednisolone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Pentoxifylline—Infection—Dexamethasone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Pentoxifylline—Infection—Betamethasone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Pentoxifylline—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00233	0.00233	CcSEcCtD
Pentoxifylline—Anaemia—Prednisone—psoriatic arthritis	0.00233	0.00233	CcSEcCtD
Pentoxifylline—Shock—Betamethasone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Pentoxifylline—Shock—Dexamethasone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Pentoxifylline—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Pentoxifylline—Agitation—Prednisone—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Pentoxifylline—Tachycardia—Dexamethasone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Pentoxifylline—Tachycardia—Betamethasone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Pentoxifylline—Angioedema—Prednisone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Pentoxifylline—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00229	0.00229	CcSEcCtD
Pentoxifylline—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Pentoxifylline—Malaise—Prednisone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Pentoxifylline—Anorexia—Betamethasone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Pentoxifylline—Anorexia—Dexamethasone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Pentoxifylline—Urticaria—Prednisolone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Pentoxifylline—Hypotension—Dexamethasone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Pentoxifylline—Hypotension—Betamethasone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Pentoxifylline—Immune system disorder—Methotrexate—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Pentoxifylline—Convulsion—Prednisone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Pentoxifylline—Hypertension—Prednisone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Pentoxifylline—Myalgia—Prednisone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Pentoxifylline—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Pentoxifylline—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Pentoxifylline—Anxiety—Prednisone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Pentoxifylline—Insomnia—Dexamethasone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Pentoxifylline—Insomnia—Betamethasone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00212	0.00212	CcSEcCtD
Pentoxifylline—Discomfort—Prednisone—psoriatic arthritis	0.00212	0.00212	CcSEcCtD
Pentoxifylline—Erythema—Methotrexate—psoriatic arthritis	0.0021	0.0021	CcSEcCtD
Pentoxifylline—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Pentoxifylline—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Pentoxifylline—Dyspepsia—Betamethasone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Pentoxifylline—Urticaria—Triamcinolone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Pentoxifylline—Urticaria—Methylprednisolone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Pentoxifylline—Dysgeusia—Methotrexate—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Pentoxifylline—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Pentoxifylline—Oedema—Prednisone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Pentoxifylline—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Pentoxifylline—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Pentoxifylline—Decreased appetite—Betamethasone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Pentoxifylline—Infection—Prednisone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Pentoxifylline—Back pain—Methotrexate—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Pentoxifylline—Shock—Prednisone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Pentoxifylline—Tachycardia—Prednisone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Pentoxifylline—Skin disorder—Prednisone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Pentoxifylline—Vision blurred—Methotrexate—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Pentoxifylline—Anorexia—Prednisone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Pentoxifylline—Anaemia—Methotrexate—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Pentoxifylline—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Pentoxifylline—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Pentoxifylline—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Pentoxifylline—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Pentoxifylline—Malaise—Methotrexate—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Pentoxifylline—Leukopenia—Methotrexate—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Pentoxifylline—Urticaria—Betamethasone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Pentoxifylline—Urticaria—Dexamethasone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Pentoxifylline—Dizziness—Prednisolone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Pentoxifylline—Asthenia—Triamcinolone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Pentoxifylline—Body temperature increased—Betamethasone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Pentoxifylline—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Pentoxifylline—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Pentoxifylline—Abdominal pain—Betamethasone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Pentoxifylline—Asthenia—Methylprednisolone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Pentoxifylline—Insomnia—Prednisone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Pentoxifylline—Pruritus—Triamcinolone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Pentoxifylline—Pruritus—Methylprednisolone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Pentoxifylline—Convulsion—Methotrexate—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Pentoxifylline—Dyspepsia—Prednisone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Pentoxifylline—Chest pain—Methotrexate—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Pentoxifylline—Myalgia—Methotrexate—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Pentoxifylline—Decreased appetite—Prednisone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Pentoxifylline—Rash—Prednisolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Pentoxifylline—Dermatitis—Prednisolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Pentoxifylline—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Pentoxifylline—Headache—Prednisolone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Pentoxifylline—Discomfort—Methotrexate—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Pentoxifylline—Constipation—Prednisone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Pentoxifylline—Confusional state—Methotrexate—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Pentoxifylline—Dizziness—Triamcinolone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Pentoxifylline—Dizziness—Methylprednisolone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Pentoxifylline—Infection—Methotrexate—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Pentoxifylline—Feeling abnormal—Prednisone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Pentoxifylline—Asthenia—Dexamethasone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Pentoxifylline—Asthenia—Betamethasone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Pentoxifylline—Nausea—Prednisolone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Pentoxifylline—Pruritus—Dexamethasone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Pentoxifylline—Pruritus—Betamethasone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Pentoxifylline—Skin disorder—Methotrexate—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Pentoxifylline—Vomiting—Triamcinolone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Pentoxifylline—Vomiting—Methylprednisolone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Pentoxifylline—Rash—Triamcinolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Pentoxifylline—Dermatitis—Triamcinolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Pentoxifylline—Anorexia—Methotrexate—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Pentoxifylline—Rash—Methylprednisolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Pentoxifylline—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Pentoxifylline—Urticaria—Prednisone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Pentoxifylline—Headache—Triamcinolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Pentoxifylline—Headache—Methylprednisolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Pentoxifylline—Body temperature increased—Prednisone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Pentoxifylline—Abdominal pain—Prednisone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Pentoxifylline—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Pentoxifylline—Diarrhoea—Betamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Pentoxifylline—Hypotension—Methotrexate—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Pentoxifylline—Dizziness—Dexamethasone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Pentoxifylline—Dizziness—Betamethasone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Pentoxifylline—Insomnia—Methotrexate—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Pentoxifylline—Nausea—Triamcinolone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Pentoxifylline—Nausea—Methylprednisolone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Pentoxifylline—Dyspnoea—Methotrexate—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Pentoxifylline—Somnolence—Methotrexate—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Pentoxifylline—Hypersensitivity—Prednisone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Pentoxifylline—Dyspepsia—Methotrexate—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Pentoxifylline—Vomiting—Dexamethasone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Pentoxifylline—Vomiting—Betamethasone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Pentoxifylline—Decreased appetite—Methotrexate—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Pentoxifylline—Rash—Betamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Pentoxifylline—Rash—Dexamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Pentoxifylline—Dermatitis—Betamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Pentoxifylline—Dermatitis—Dexamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Pentoxifylline—Headache—Dexamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Pentoxifylline—Headache—Betamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Pentoxifylline—Asthenia—Prednisone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Pentoxifylline—Pruritus—Prednisone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Pentoxifylline—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Pentoxifylline—Diarrhoea—Prednisone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Pentoxifylline—Nausea—Dexamethasone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Pentoxifylline—Nausea—Betamethasone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Pentoxifylline—Urticaria—Methotrexate—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Pentoxifylline—Dizziness—Prednisone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Pentoxifylline—Abdominal pain—Methotrexate—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Pentoxifylline—Body temperature increased—Methotrexate—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Pentoxifylline—Vomiting—Prednisone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Pentoxifylline—Rash—Prednisone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Pentoxifylline—Dermatitis—Prednisone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Pentoxifylline—Headache—Prednisone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Pentoxifylline—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Pentoxifylline—Asthenia—Methotrexate—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Pentoxifylline—Nausea—Prednisone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Pentoxifylline—Pruritus—Methotrexate—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Pentoxifylline—Diarrhoea—Methotrexate—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Pentoxifylline—Dizziness—Methotrexate—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Pentoxifylline—Vomiting—Methotrexate—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Pentoxifylline—Rash—Methotrexate—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Pentoxifylline—Dermatitis—Methotrexate—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Pentoxifylline—Headache—Methotrexate—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Pentoxifylline—Nausea—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
